Overview

Ixabepilone and SBRT For Metastatic Breast Cancer

Status:
Withdrawn

Trial end date:
2015-04-01

Target enrollment:

Participant gender:

Summary

This study is being done to find the effect of Stereotactic body radiation therapy (SBRT) in combination with Ixabepilone for women with triple negative metastatic breast cancer.

Phase:

Phase 2

Details

Lead Sponsor:

University of Texas Southwestern Medical Center

Treatments:

Epothilones